|
|
|
09500HB0118sam001 |
- 2 - |
LRB095 03934 RAS 35945 a |
|
|
1 |
| (b) Persons holding underserved population dental licenses |
2 |
| may practice only in federally-designated dental health |
3 |
| professional shortage areas located in this State and must meet |
4 |
| each of the following qualifications: |
5 |
| (1) He or she must be a United States citizen or a |
6 |
| lawfully-admitted alien. |
7 |
| (2) He or she must be at least 21 years of age and of |
8 |
| good moral character. |
9 |
| (3) He or she must pass an examination authorized or |
10 |
| given by the Department in the theory and practice of the |
11 |
| science of dentistry, provided that the Department (i) may |
12 |
| recognize a certificate granted by the National Board of |
13 |
| Dental Examiners in lieu of or subject to such examination, |
14 |
| as may be required and (ii) may recognize the successful |
15 |
| completion of the clinical examination conducted by |
16 |
| approved regional testing services in lieu of such |
17 |
| examinations, as may be required. For the purposes of this |
18 |
| item (3), "successful completion" means that the applicant |
19 |
| has achieved a minimum passing score on the regional |
20 |
| examinations, as determined by each approved regional |
21 |
| testing service. |
22 |
| (4) He or she must present satisfactory evidence of the |
23 |
| completion of dental education by graduation from a dental |
24 |
| college or school outside of the United States or Canada |
25 |
| and provide satisfactory evidence that he or she has |
26 |
| achieved the same level of scientific knowledge and |
|
|
|
09500HB0118sam001 |
- 3 - |
LRB095 03934 RAS 35945 a |
|
|
1 |
| clinical competence as required of all graduates of the |
2 |
| college, school, or advanced dental education program. |
3 |
| (c) In determining an applicant's professional capacity |
4 |
| for licensure under the pilot program, an individual who (i) |
5 |
| has not been actively engaged in the practice of dentistry, |
6 |
| (ii) has not been a dental student, or (iii) has not been |
7 |
| engaged in a formal program of dental education during the 5 |
8 |
| years immediately preceding the filing of an application may be |
9 |
| required to complete such additional testing, training, or |
10 |
| remedial education as the Board may deem necessary to establish |
11 |
| the applicant's present capacity to practice dentistry with |
12 |
| reasonable judgment, skill, and safety.
|
13 |
| (d) All candidates for licensure under the pilot program |
14 |
| must be certified by the Department. The Department may |
15 |
| contract with outside consultants or a national professional |
16 |
| organization to survey and evaluate candidates. Such |
17 |
| consultant or organization shall report to the Department |
18 |
| regarding its findings. |
19 |
| (e) An applicant for licensure under the pilot program who |
20 |
| has graduated from a dental education program outside of the |
21 |
| United States or Canada or its territories and whose first |
22 |
| language is not English must submit certification of passage of |
23 |
| the Test of English as a Foreign Language (TOEFL), as defined |
24 |
| by rule. The Department may, upon recommendation of the |
25 |
| certifying body, waive the requirement that the applicant pass |
26 |
| the TOEFL examination if the applicant submits verification of |
|
|
|
09500HB0118sam001 |
- 4 - |
LRB095 03934 RAS 35945 a |
|
|
1 |
| the successful completion of a dental education program |
2 |
| conducted in English. |
3 |
| (f) Underserved population dental licensees must agree to |
4 |
| provide all allowable services under the dental programs |
5 |
| administered by the Department of Healthcare and Family |
6 |
| Services, including the Medicaid Program and the Covering ALL |
7 |
| KIDS Health Insurance Program. These allowable services |
8 |
| include without limitation preventative treatments, |
9 |
| endodontics, and crown and bridge work. An underserved |
10 |
| population dental licensee may not refuse to treat a patient |
11 |
| eligible under dental programs administered by the Department |
12 |
| of Healthcare and Family Services. |
13 |
| (g) An underserved population dental license shall be |
14 |
| automatically revoked if the licensee ceases to practice in the |
15 |
| federally-designated dental health professional shortage area. |
16 |
| An applicant must commit to practice under an underserved |
17 |
| population dental license for a period of 5 years. No more than |
18 |
| 50 underserved population dental licenses may be active at one |
19 |
| time. |
20 |
| (h) An underserved population dental licensee must be |
21 |
| supervised by a supervising dentist. The supervising dentist |
22 |
| shall be the primary dentist who, within his or her expertise, |
23 |
| may delegate a variety of tasks and procedures and may delegate |
24 |
| prescriptive authority to the underserved dental population |
25 |
| licensee. These tasks and procedures must be delegated within |
26 |
| established guidelines and the supervising dentist shall |
|
|
|
09500HB0118sam001 |
- 5 - |
LRB095 03934 RAS 35945 a |
|
|
1 |
| maintain the final responsibility for the care of all patients |
2 |
| and the performance of the underserved population dental |
3 |
| licensee. Underserved population dental licensees may be |
4 |
| supervised only by dentists, as defined in this Act, who are |
5 |
| engaged in clinical practice or in clinical practice in public |
6 |
| health or other community health facilities. Each supervising |
7 |
| dentist shall file a notice of supervision of an underserved |
8 |
| population dental licensee, as established by rule. |
9 |
| An underserved population dental licensee may be employed |
10 |
| by a practice group or other entity employing multiple dentists |
11 |
| at one or more locations. In that case, one of the dentists |
12 |
| practicing at a location shall be designated the supervising |
13 |
| dentist. The other dentists with that practice group or other |
14 |
| entity who practice in the same general type of practice or |
15 |
| specialty as the supervising dentist may supervise the |
16 |
| underserved population dental licensees with respect to their |
17 |
| patients without being deemed alternate supervising dentists |
18 |
| for the purposes of this Section. |
19 |
| Nothing in this Section shall be construed to limit the |
20 |
| delegation of tasks or duties by a dentist to an underserved |
21 |
| dental population licensee or other appropriately trained |
22 |
| personnel. |
23 |
| Nothing in this Section shall be construed to prohibit the |
24 |
| employment of underserved population dental licensees by a |
25 |
| health care facility where such licensees function under the |
26 |
| supervision of a supervising dentist.
Duties of each |
|
|
|
09500HB0118sam001 |
- 6 - |
LRB095 03934 RAS 35945 a |
|
|
1 |
| underserved population dental licensee are limited to those |
2 |
| within the scope of practice of the supervising dentist who is |
3 |
| fully responsible for all underserved dental population |
4 |
| licensee activities. |
5 |
| (i) Beginning 5 years after the effective date of this |
6 |
| amendatory Act of the 95th General Assembly, no new licenses |
7 |
| may be issued under the pilot program.
|
8 |
| (j) The Department shall adopt all rules necessary for the |
9 |
| administration of this Section.
|
10 |
| Section 10. The Illinois Controlled Substances Act is |
11 |
| amended by changing Section 102 as follows: |
12 |
| (720 ILCS 570/102) (from Ch. 56 1/2, par. 1102) |
13 |
| Sec. 102. Definitions. As used in this Act, unless the |
14 |
| context
otherwise requires:
|
15 |
| (a) "Addict" means any person who habitually uses any drug, |
16 |
| chemical,
substance or dangerous drug other than alcohol so as |
17 |
| to endanger the public
morals, health, safety or welfare or who |
18 |
| is so far addicted to the use of a
dangerous drug or controlled |
19 |
| substance other than alcohol as to have lost
the power of self |
20 |
| control with reference to his addiction.
|
21 |
| (b) "Administer" means the direct application of a |
22 |
| controlled
substance, whether by injection, inhalation, |
23 |
| ingestion, or any other
means, to the body of a patient, |
24 |
| research subject, or animal (as
defined by the Humane |
|
|
|
09500HB0118sam001 |
- 7 - |
LRB095 03934 RAS 35945 a |
|
|
1 |
| Euthanasia in Animal Shelters Act) by:
|
2 |
| (1) a practitioner (or, in his presence, by his |
3 |
| authorized agent),
|
4 |
| (2) the patient or research subject at the lawful |
5 |
| direction of the
practitioner, or
|
6 |
| (3) a euthanasia technician as defined by the Humane |
7 |
| Euthanasia in
Animal Shelters Act.
|
8 |
| (c) "Agent" means an authorized person who acts on behalf |
9 |
| of or at
the direction of a manufacturer, distributor, or |
10 |
| dispenser. It does not
include a common or contract carrier, |
11 |
| public warehouseman or employee of
the carrier or warehouseman.
|
12 |
| (c-1) "Anabolic Steroids" means any drug or hormonal |
13 |
| substance,
chemically and pharmacologically related to |
14 |
| testosterone (other than
estrogens, progestins, and |
15 |
| corticosteroids) that promotes muscle growth,
and includes:
|
16 |
| (i) boldenone,
|
17 |
| (ii) chlorotestosterone,
|
18 |
| (iii) chostebol,
|
19 |
| (iv) dehydrochlormethyltestosterone,
|
20 |
| (v) dihydrotestosterone,
|
21 |
| (vi) drostanolone,
|
22 |
| (vii) ethylestrenol,
|
23 |
| (viii) fluoxymesterone,
|
24 |
| (ix) formebulone,
|
25 |
| (x) mesterolone,
|
26 |
| (xi) methandienone,
|
|
|
|
09500HB0118sam001 |
- 8 - |
LRB095 03934 RAS 35945 a |
|
|
1 |
| (xii) methandranone,
|
2 |
| (xiii) methandriol,
|
3 |
| (xiv) methandrostenolone,
|
4 |
| (xv) methenolone,
|
5 |
| (xvi) methyltestosterone,
|
6 |
| (xvii) mibolerone,
|
7 |
| (xviii) nandrolone,
|
8 |
| (xix) norethandrolone,
|
9 |
| (xx) oxandrolone,
|
10 |
| (xxi) oxymesterone,
|
11 |
| (xxii) oxymetholone,
|
12 |
| (xxiii) stanolone,
|
13 |
| (xxiv) stanozolol,
|
14 |
| (xxv) testolactone,
|
15 |
| (xxvi) testosterone,
|
16 |
| (xxvii) trenbolone, and
|
17 |
| (xxviii) any salt, ester, or isomer of a drug or |
18 |
| substance described
or listed in this paragraph, if |
19 |
| that salt, ester, or isomer promotes muscle
growth.
|
20 |
| Any person who is otherwise lawfully in possession of an |
21 |
| anabolic
steroid, or who otherwise lawfully manufactures, |
22 |
| distributes, dispenses,
delivers, or possesses with intent to |
23 |
| deliver an anabolic steroid, which
anabolic steroid is |
24 |
| expressly intended for and lawfully allowed to be
administered |
25 |
| through implants to livestock or other nonhuman species, and
|
26 |
| which is approved by the Secretary of Health and Human Services |
|
|
|
09500HB0118sam001 |
- 9 - |
LRB095 03934 RAS 35945 a |
|
|
1 |
| for such
administration, and which the person intends to |
2 |
| administer or have
administered through such implants, shall |
3 |
| not be considered to be in
unauthorized possession or to |
4 |
| unlawfully manufacture, distribute, dispense,
deliver, or |
5 |
| possess with intent to deliver such anabolic steroid for
|
6 |
| purposes of this Act.
|
7 |
| (d) "Administration" means the Drug Enforcement |
8 |
| Administration,
United States Department of Justice, or its |
9 |
| successor agency.
|
10 |
| (e) "Control" means to add a drug or other substance, or |
11 |
| immediate
precursor, to a Schedule under Article II of this Act |
12 |
| whether by
transfer from another Schedule or otherwise.
|
13 |
| (f) "Controlled Substance" means a drug, substance, or |
14 |
| immediate
precursor in the Schedules of Article II of this Act.
|
15 |
| (g) "Counterfeit substance" means a controlled substance, |
16 |
| which, or
the container or labeling of which, without |
17 |
| authorization bears the
trademark, trade name, or other |
18 |
| identifying mark, imprint, number or
device, or any likeness |
19 |
| thereof, of a manufacturer, distributor, or
dispenser other |
20 |
| than the person who in fact manufactured, distributed,
or |
21 |
| dispensed the substance.
|
22 |
| (h) "Deliver" or "delivery" means the actual, constructive |
23 |
| or
attempted transfer of possession of a controlled substance, |
24 |
| with or
without consideration, whether or not there is an |
25 |
| agency relationship.
|
26 |
| (i) "Department" means the Illinois Department of Human |
|
|
|
09500HB0118sam001 |
- 10 - |
LRB095 03934 RAS 35945 a |
|
|
1 |
| Services (as
successor to the Department of Alcoholism and |
2 |
| Substance Abuse) or its successor agency.
|
3 |
| (j) "Department of State Police" means the Department of |
4 |
| State
Police of the State of Illinois or its successor agency.
|
5 |
| (k) "Department of Corrections" means the Department of |
6 |
| Corrections
of the State of Illinois or its successor agency.
|
7 |
| (l) "Department of Professional Regulation" means the |
8 |
| Department
of Professional Regulation of the State of Illinois |
9 |
| or its successor agency.
|
10 |
| (m) "Depressant" or "stimulant substance" means:
|
11 |
| (1) a drug which contains any quantity of (i) |
12 |
| barbituric acid or
any of the salts of barbituric acid |
13 |
| which has been designated as habit
forming under section |
14 |
| 502 (d) of the Federal Food, Drug, and Cosmetic
Act (21 |
15 |
| U.S.C. 352 (d)); or
|
16 |
| (2) a drug which contains any quantity of (i) |
17 |
| amphetamine or
methamphetamine and any of their optical |
18 |
| isomers; (ii) any salt of
amphetamine or methamphetamine or |
19 |
| any salt of an optical isomer of
amphetamine; or (iii) any |
20 |
| substance which the Department, after
investigation, has |
21 |
| found to be, and by rule designated as, habit forming
|
22 |
| because of its depressant or stimulant effect on the |
23 |
| central nervous
system; or
|
24 |
| (3) lysergic acid diethylamide; or
|
25 |
| (4) any drug which contains any quantity of a substance |
26 |
| which the
Department, after investigation, has found to |
|
|
|
09500HB0118sam001 |
- 11 - |
LRB095 03934 RAS 35945 a |
|
|
1 |
| have, and by rule
designated as having, a potential for |
2 |
| abuse because of its depressant or
stimulant effect on the |
3 |
| central nervous system or its hallucinogenic
effect.
|
4 |
| (n) (Blank).
|
5 |
| (o) "Director" means the Director of the Department of |
6 |
| State Police or
the Department of Professional Regulation or |
7 |
| his designated agents.
|
8 |
| (p) "Dispense" means to deliver a controlled substance to |
9 |
| an
ultimate user or research subject by or pursuant to the |
10 |
| lawful order of
a prescriber, including the prescribing, |
11 |
| administering, packaging,
labeling, or compounding necessary |
12 |
| to prepare the substance for that
delivery.
|
13 |
| (q) "Dispenser" means a practitioner who dispenses.
|
14 |
| (r) "Distribute" means to deliver, other than by |
15 |
| administering or
dispensing, a controlled substance.
|
16 |
| (s) "Distributor" means a person who distributes.
|
17 |
| (t) "Drug" means (1) substances recognized as drugs in the |
18 |
| official
United States Pharmacopoeia, Official Homeopathic |
19 |
| Pharmacopoeia of the
United States, or official National |
20 |
| Formulary, or any supplement to any
of them; (2) substances |
21 |
| intended for use in diagnosis, cure, mitigation,
treatment, or |
22 |
| prevention of disease in man or animals; (3) substances
(other |
23 |
| than food) intended to affect the structure of any function of
|
24 |
| the body of man or animals and (4) substances intended for use |
25 |
| as a
component of any article specified in clause (1), (2), or |
26 |
| (3) of this
subsection. It does not include devices or their |
|
|
|
09500HB0118sam001 |
- 12 - |
LRB095 03934 RAS 35945 a |
|
|
1 |
| components, parts, or
accessories.
|
2 |
| (t-5) "Euthanasia agency" means
an entity certified by the |
3 |
| Department of Professional Regulation for the
purpose of animal |
4 |
| euthanasia that holds an animal control facility license or
|
5 |
| animal
shelter license under the Animal Welfare Act. A |
6 |
| euthanasia agency is
authorized to purchase, store, possess, |
7 |
| and utilize Schedule II nonnarcotic and
Schedule III |
8 |
| nonnarcotic drugs for the sole purpose of animal euthanasia.
|
9 |
| (t-10) "Euthanasia drugs" means Schedule II or Schedule III |
10 |
| substances
(nonnarcotic controlled substances) that are used |
11 |
| by a euthanasia agency for
the purpose of animal euthanasia.
|
12 |
| (u) "Good faith" means the prescribing or dispensing of a |
13 |
| controlled
substance by a practitioner in the regular course of |
14 |
| professional
treatment to or for any person who is under his |
15 |
| treatment for a
pathology or condition other than that |
16 |
| individual's physical or
psychological dependence upon or |
17 |
| addiction to a controlled substance,
except as provided herein: |
18 |
| and application of the term to a pharmacist
shall mean the |
19 |
| dispensing of a controlled substance pursuant to the
|
20 |
| prescriber's order which in the professional judgment of the |
21 |
| pharmacist
is lawful. The pharmacist shall be guided by |
22 |
| accepted professional
standards including, but not limited to |
23 |
| the following, in making the
judgment:
|
24 |
| (1) lack of consistency of doctor-patient |
25 |
| relationship,
|
26 |
| (2) frequency of prescriptions for same drug by one |
|
|
|
09500HB0118sam001 |
- 13 - |
LRB095 03934 RAS 35945 a |
|
|
1 |
| prescriber for
large numbers of patients,
|
2 |
| (3) quantities beyond those normally prescribed,
|
3 |
| (4) unusual dosages,
|
4 |
| (5) unusual geographic distances between patient, |
5 |
| pharmacist and
prescriber,
|
6 |
| (6) consistent prescribing of habit-forming drugs.
|
7 |
| (u-1) "Home infusion services" means services provided by a |
8 |
| pharmacy in
compounding solutions for direct administration to |
9 |
| a patient in a private
residence, long-term care facility, or |
10 |
| hospice setting by means of parenteral,
intravenous, |
11 |
| intramuscular, subcutaneous, or intraspinal infusion.
|
12 |
| (v) "Immediate precursor" means a substance:
|
13 |
| (1) which the Department has found to be and by rule |
14 |
| designated as
being a principal compound used, or produced |
15 |
| primarily for use, in the
manufacture of a controlled |
16 |
| substance;
|
17 |
| (2) which is an immediate chemical intermediary used or |
18 |
| likely to
be used in the manufacture of such controlled |
19 |
| substance; and
|
20 |
| (3) the control of which is necessary to prevent, |
21 |
| curtail or limit
the manufacture of such controlled |
22 |
| substance.
|
23 |
| (w) "Instructional activities" means the acts of teaching, |
24 |
| educating
or instructing by practitioners using controlled |
25 |
| substances within
educational facilities approved by the State |
26 |
| Board of Education or
its successor agency.
|
|
|
|
09500HB0118sam001 |
- 14 - |
LRB095 03934 RAS 35945 a |
|
|
1 |
| (x) "Local authorities" means a duly organized State, |
2 |
| County or
Municipal peace unit or police force.
|
3 |
| (y) "Look-alike substance" means a substance, other than a |
4 |
| controlled
substance which (1) by overall dosage unit |
5 |
| appearance, including shape,
color, size, markings or lack |
6 |
| thereof, taste, consistency, or any other
identifying physical |
7 |
| characteristic of the substance, would lead a reasonable
person |
8 |
| to believe that the substance is a controlled substance, or (2) |
9 |
| is
expressly or impliedly represented to be a controlled |
10 |
| substance or is
distributed under circumstances which would |
11 |
| lead a reasonable person to
believe that the substance is a |
12 |
| controlled substance. For the purpose of
determining whether |
13 |
| the representations made or the circumstances of the
|
14 |
| distribution would lead a reasonable person to believe the |
15 |
| substance to be
a controlled substance under this clause (2) of |
16 |
| subsection (y), the court or
other authority may consider the |
17 |
| following factors in addition to any other
factor that may be |
18 |
| relevant:
|
19 |
| (a) statements made by the owner or person in control |
20 |
| of the substance
concerning its nature, use or effect;
|
21 |
| (b) statements made to the buyer or recipient that the |
22 |
| substance may
be resold for profit;
|
23 |
| (c) whether the substance is packaged in a manner |
24 |
| normally used for the
illegal distribution of controlled |
25 |
| substances;
|
26 |
| (d) whether the distribution or attempted distribution |
|
|
|
09500HB0118sam001 |
- 15 - |
LRB095 03934 RAS 35945 a |
|
|
1 |
| included an
exchange of or demand for money or other |
2 |
| property as consideration, and
whether the amount of the |
3 |
| consideration was substantially greater than the
|
4 |
| reasonable retail market value of the substance.
|
5 |
| Clause (1) of this subsection (y) shall not apply to a |
6 |
| noncontrolled
substance in its finished dosage form that was |
7 |
| initially introduced into
commerce prior to the initial |
8 |
| introduction into commerce of a controlled
substance in its |
9 |
| finished dosage form which it may substantially resemble.
|
10 |
| Nothing in this subsection (y) prohibits the dispensing or |
11 |
| distributing
of noncontrolled substances by persons authorized |
12 |
| to dispense and
distribute controlled substances under this |
13 |
| Act, provided that such action
would be deemed to be carried |
14 |
| out in good faith under subsection (u) if the
substances |
15 |
| involved were controlled substances.
|
16 |
| Nothing in this subsection (y) or in this Act prohibits the |
17 |
| manufacture,
preparation, propagation, compounding, |
18 |
| processing, packaging, advertising
or distribution of a drug or |
19 |
| drugs by any person registered pursuant to
Section 510 of the |
20 |
| Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360).
|
21 |
| (y-1) "Mail-order pharmacy" means a pharmacy that is |
22 |
| located in a state
of the United States, other than Illinois, |
23 |
| that delivers, dispenses or
distributes, through the United |
24 |
| States Postal Service or other common
carrier, to Illinois |
25 |
| residents, any substance which requires a prescription.
|
26 |
| (z) "Manufacture" means the production, preparation, |
|
|
|
09500HB0118sam001 |
- 16 - |
LRB095 03934 RAS 35945 a |
|
|
1 |
| propagation,
compounding, conversion or processing of a |
2 |
| controlled substance other than methamphetamine, either
|
3 |
| directly or indirectly, by extraction from substances of |
4 |
| natural origin,
or independently by means of chemical |
5 |
| synthesis, or by a combination of
extraction and chemical |
6 |
| synthesis, and includes any packaging or
repackaging of the |
7 |
| substance or labeling of its container, except that
this term |
8 |
| does not include:
|
9 |
| (1) by an ultimate user, the preparation or compounding |
10 |
| of a
controlled substance for his own use; or
|
11 |
| (2) by a practitioner, or his authorized agent under |
12 |
| his
supervision, the preparation, compounding, packaging, |
13 |
| or labeling of a
controlled substance:
|
14 |
| (a) as an incident to his administering or |
15 |
| dispensing of a
controlled substance in the course of |
16 |
| his professional practice; or
|
17 |
| (b) as an incident to lawful research, teaching or |
18 |
| chemical
analysis and not for sale.
|
19 |
| (z-1) (Blank).
|
20 |
| (aa) "Narcotic drug" means any of the following, whether |
21 |
| produced
directly or indirectly by extraction from substances |
22 |
| of natural origin,
or independently by means of chemical |
23 |
| synthesis, or by a combination of
extraction and chemical |
24 |
| synthesis:
|
25 |
| (1) opium and opiate, and any salt, compound, |
26 |
| derivative, or
preparation of opium or opiate;
|
|
|
|
09500HB0118sam001 |
- 17 - |
LRB095 03934 RAS 35945 a |
|
|
1 |
| (2) any salt, compound, isomer, derivative, or |
2 |
| preparation thereof
which is chemically equivalent or |
3 |
| identical with any of the substances
referred to in clause |
4 |
| (1), but not including the isoquinoline alkaloids
of opium;
|
5 |
| (3) opium poppy and poppy straw;
|
6 |
| (4) coca leaves and any salts, compound, isomer, salt |
7 |
| of an isomer,
derivative, or preparation of coca leaves |
8 |
| including cocaine or ecgonine,
and any salt, compound, |
9 |
| isomer, derivative, or preparation thereof which is
|
10 |
| chemically equivalent or identical with any of these |
11 |
| substances, but not
including decocainized coca leaves or |
12 |
| extractions of coca leaves which do
not contain cocaine or |
13 |
| ecgonine (for the purpose of this paragraph, the
term |
14 |
| "isomer" includes optical, positional and geometric |
15 |
| isomers).
|
16 |
| (bb) "Nurse" means a registered nurse licensed under the
|
17 |
| Nursing and Advanced Practice Nursing Act.
|
18 |
| (cc) (Blank).
|
19 |
| (dd) "Opiate" means any substance having an addiction |
20 |
| forming or
addiction sustaining liability similar to morphine |
21 |
| or being capable of
conversion into a drug having addiction |
22 |
| forming or addiction sustaining
liability.
|
23 |
| (ee) "Opium poppy" means the plant of the species Papaver
|
24 |
| somniferum L., except its seeds.
|
25 |
| (ff) "Parole and Pardon Board" means the Parole and Pardon |
26 |
| Board of
the State of Illinois or its successor agency.
|
|
|
|
09500HB0118sam001 |
- 18 - |
LRB095 03934 RAS 35945 a |
|
|
1 |
| (gg) "Person" means any individual, corporation, |
2 |
| mail-order pharmacy,
government or governmental subdivision or |
3 |
| agency, business trust, estate,
trust, partnership or |
4 |
| association, or any other entity.
|
5 |
| (hh) "Pharmacist" means any person who holds a certificate |
6 |
| of
registration as a registered pharmacist, a local registered |
7 |
| pharmacist
or a registered assistant pharmacist under the |
8 |
| Pharmacy Practice Act of 1987.
|
9 |
| (ii) "Pharmacy" means any store, ship or other place in |
10 |
| which
pharmacy is authorized to be practiced under the Pharmacy |
11 |
| Practice Act of 1987.
|
12 |
| (jj) "Poppy straw" means all parts, except the seeds, of |
13 |
| the opium
poppy, after mowing.
|
14 |
| (kk) "Practitioner" means a physician licensed to practice |
15 |
| medicine in all
its branches, dentist, podiatrist,
|
16 |
| veterinarian, scientific investigator, pharmacist, physician |
17 |
| assistant,
advanced practice nurse,
licensed practical
nurse, |
18 |
| registered nurse, hospital, laboratory, or pharmacy, or other
|
19 |
| person licensed, registered, or otherwise lawfully permitted |
20 |
| by the
United States or this State to distribute, dispense, |
21 |
| conduct research
with respect to, administer or use in teaching |
22 |
| or chemical analysis, a
controlled substance in the course of |
23 |
| professional practice or research.
|
24 |
| (ll) "Pre-printed prescription" means a written |
25 |
| prescription upon which
the designated drug has been indicated |
26 |
| prior to the time of issuance.
|
|
|
|
09500HB0118sam001 |
- 19 - |
LRB095 03934 RAS 35945 a |
|
|
1 |
| (mm) "Prescriber" means a physician licensed to practice |
2 |
| medicine in all
its branches, dentist, podiatrist or
|
3 |
| veterinarian who issues a prescription, a physician assistant |
4 |
| who
issues a
prescription for a Schedule III, IV, or V |
5 |
| controlled substance
in accordance
with Section 303.05 and the |
6 |
| written guidelines required under Section 7.5
of the
Physician |
7 |
| Assistant Practice Act of 1987, or an advanced practice
nurse |
8 |
| with prescriptive authority in accordance with Section 303.05
|
9 |
| and a written
collaborative agreement under Sections 15-15 and |
10 |
| 15-20 of
the Nursing and Advanced Practice Nursing Act , or an |
11 |
| underserved dental population licensee with prescriptive |
12 |
| authority in accordance with Section 11.5 of the Illinois |
13 |
| Dental Practice Act .
|
14 |
| (nn) "Prescription" means a lawful written, facsimile, or |
15 |
| verbal order
of
a physician licensed to practice medicine in |
16 |
| all its branches,
dentist, podiatrist or veterinarian for any |
17 |
| controlled
substance, of a physician assistant for a Schedule |
18 |
| III, IV, or V
controlled substance
in accordance with Section |
19 |
| 303.05 and the written guidelines required under
Section 7.5 of |
20 |
| the
Physician Assistant Practice Act of 1987, or of an advanced |
21 |
| practice
nurse who issues a prescription for a Schedule III, |
22 |
| IV, or V
controlled substance in accordance
with
Section 303.05 |
23 |
| and a written collaborative agreement under Sections 15-15
and
|
24 |
| 15-20 of the Nursing and Advanced Practice Nursing Act.
|
25 |
| (oo) "Production" or "produce" means manufacture, |
26 |
| planting,
cultivating, growing, or harvesting of a controlled |
|
|
|
09500HB0118sam001 |
- 20 - |
LRB095 03934 RAS 35945 a |
|
|
1 |
| substance other than methamphetamine.
|
2 |
| (pp) "Registrant" means every person who is required to |
3 |
| register
under Section 302 of this Act.
|
4 |
| (qq) "Registry number" means the number assigned to each |
5 |
| person
authorized to handle controlled substances under the |
6 |
| laws of the United
States and of this State.
|
7 |
| (rr) "State" includes the State of Illinois and any state, |
8 |
| district,
commonwealth, territory, insular possession thereof, |
9 |
| and any area
subject to the legal authority of the United |
10 |
| States of America.
|
11 |
| (ss) "Ultimate user" means a person who lawfully possesses |
12 |
| a
controlled substance for his own use or for the use of a |
13 |
| member of his
household or for administering to an animal owned |
14 |
| by him or by a member
of his household.
|
15 |
| (Source: P.A. 93-596, eff. 8-26-03; 93-626, eff. 12-23-03; |
16 |
| 94-556, eff. 9-11-05.)
|
17 |
| Section 99. Effective date. This Act takes effect upon |
18 |
| becoming law.".
|